Proposed new diagnostic criteria for chronic migraine

Mona Ameri Chalmer, Thomas Folkmann Hansen, Elena R. Lebedeva, David W. Dodick, Richard B. Lipton, Jes Olesen

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Introduction: ICHD-3 criteria for chronic migraine (CM) include a mixture of migraine and tension-type-like headaches and do not account for patients who have a high frequency of migraine but no other headaches. Materials and methods: Patients from the Danish Headache Center and their relatives with ICHD-3 defined CM were compared with patients with high frequency episodic migraine (HFEM). Danish registries were used to compare the socioeconomic impact in these two groups. A Russian student population was used to determine the generalizability of the number of patients fulfilling CM and the proposed diagnostic criteria for CM. Results: There was no difference in the demographic profile between the two groups in the Danish cohort. The number of lifelong or annual attacks (p > 0.3), comorbid diseases, or self-reported effect of triptans (p = 1) did not differ. HFEM patients purchased more triptans than CM patients (p = 0.01). CM patients received more early pension (p = 0.00135) but did not differ from HFEM patients with regard to sickness benefit (p = 0.207), cash assistance (p = 0.139), or rehabilitation benefit (p = 1). Discussion: Patients with HFEM are comparable to CM patients with regard to chronicity and disability. We therefore suggest classifying CM as ≥ 8 migraine days per month (proposed CM), disregarding the need for ≥ 15 headache days per month. The proposed diagnostic criteria for CM approximately doubled the number of patients with CM in both the Danish and the Russian materials. Extending the definition of CM to include patients with HFEM will ensure that patients with significant disease burden and unmet treatment needs are identified and provided appropriate access to the range of treatment options and resources available to those with CM. Conclusion: Patients with migraine on eight or more days but not 15 days with headache a month are as disabled as patients with ICHD-3 defined CM. They should be included in revised diagnostic criteria for chronic migraine.

Original languageEnglish (US)
JournalCephalalgia
DOIs
StateAccepted/In press - Jan 1 2019

Fingerprint

Migraine Disorders
Headache
Tryptamines
Tension-Type Headache
Pensions

Keywords

  • chronic migraine
  • classification
  • diagnostic criteria
  • headache
  • high frequency episodic migraine
  • Migraine

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

Chalmer, M. A., Hansen, T. F., Lebedeva, E. R., Dodick, D. W., Lipton, R. B., & Olesen, J. (Accepted/In press). Proposed new diagnostic criteria for chronic migraine. Cephalalgia. https://doi.org/10.1177/0333102419877171

Proposed new diagnostic criteria for chronic migraine. / Chalmer, Mona Ameri; Hansen, Thomas Folkmann; Lebedeva, Elena R.; Dodick, David W.; Lipton, Richard B.; Olesen, Jes.

In: Cephalalgia, 01.01.2019.

Research output: Contribution to journalArticle

Chalmer, Mona Ameri ; Hansen, Thomas Folkmann ; Lebedeva, Elena R. ; Dodick, David W. ; Lipton, Richard B. ; Olesen, Jes. / Proposed new diagnostic criteria for chronic migraine. In: Cephalalgia. 2019.
@article{9d72dc557fa6493a80e53a3adb1e5ee9,
title = "Proposed new diagnostic criteria for chronic migraine",
abstract = "Introduction: ICHD-3 criteria for chronic migraine (CM) include a mixture of migraine and tension-type-like headaches and do not account for patients who have a high frequency of migraine but no other headaches. Materials and methods: Patients from the Danish Headache Center and their relatives with ICHD-3 defined CM were compared with patients with high frequency episodic migraine (HFEM). Danish registries were used to compare the socioeconomic impact in these two groups. A Russian student population was used to determine the generalizability of the number of patients fulfilling CM and the proposed diagnostic criteria for CM. Results: There was no difference in the demographic profile between the two groups in the Danish cohort. The number of lifelong or annual attacks (p > 0.3), comorbid diseases, or self-reported effect of triptans (p = 1) did not differ. HFEM patients purchased more triptans than CM patients (p = 0.01). CM patients received more early pension (p = 0.00135) but did not differ from HFEM patients with regard to sickness benefit (p = 0.207), cash assistance (p = 0.139), or rehabilitation benefit (p = 1). Discussion: Patients with HFEM are comparable to CM patients with regard to chronicity and disability. We therefore suggest classifying CM as ≥ 8 migraine days per month (proposed CM), disregarding the need for ≥ 15 headache days per month. The proposed diagnostic criteria for CM approximately doubled the number of patients with CM in both the Danish and the Russian materials. Extending the definition of CM to include patients with HFEM will ensure that patients with significant disease burden and unmet treatment needs are identified and provided appropriate access to the range of treatment options and resources available to those with CM. Conclusion: Patients with migraine on eight or more days but not 15 days with headache a month are as disabled as patients with ICHD-3 defined CM. They should be included in revised diagnostic criteria for chronic migraine.",
keywords = "chronic migraine, classification, diagnostic criteria, headache, high frequency episodic migraine, Migraine",
author = "Chalmer, {Mona Ameri} and Hansen, {Thomas Folkmann} and Lebedeva, {Elena R.} and Dodick, {David W.} and Lipton, {Richard B.} and Jes Olesen",
year = "2019",
month = "1",
day = "1",
doi = "10.1177/0333102419877171",
language = "English (US)",
journal = "Cephalalgia",
issn = "0333-1024",
publisher = "SAGE Publications Ltd",

}

TY - JOUR

T1 - Proposed new diagnostic criteria for chronic migraine

AU - Chalmer, Mona Ameri

AU - Hansen, Thomas Folkmann

AU - Lebedeva, Elena R.

AU - Dodick, David W.

AU - Lipton, Richard B.

AU - Olesen, Jes

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Introduction: ICHD-3 criteria for chronic migraine (CM) include a mixture of migraine and tension-type-like headaches and do not account for patients who have a high frequency of migraine but no other headaches. Materials and methods: Patients from the Danish Headache Center and their relatives with ICHD-3 defined CM were compared with patients with high frequency episodic migraine (HFEM). Danish registries were used to compare the socioeconomic impact in these two groups. A Russian student population was used to determine the generalizability of the number of patients fulfilling CM and the proposed diagnostic criteria for CM. Results: There was no difference in the demographic profile between the two groups in the Danish cohort. The number of lifelong or annual attacks (p > 0.3), comorbid diseases, or self-reported effect of triptans (p = 1) did not differ. HFEM patients purchased more triptans than CM patients (p = 0.01). CM patients received more early pension (p = 0.00135) but did not differ from HFEM patients with regard to sickness benefit (p = 0.207), cash assistance (p = 0.139), or rehabilitation benefit (p = 1). Discussion: Patients with HFEM are comparable to CM patients with regard to chronicity and disability. We therefore suggest classifying CM as ≥ 8 migraine days per month (proposed CM), disregarding the need for ≥ 15 headache days per month. The proposed diagnostic criteria for CM approximately doubled the number of patients with CM in both the Danish and the Russian materials. Extending the definition of CM to include patients with HFEM will ensure that patients with significant disease burden and unmet treatment needs are identified and provided appropriate access to the range of treatment options and resources available to those with CM. Conclusion: Patients with migraine on eight or more days but not 15 days with headache a month are as disabled as patients with ICHD-3 defined CM. They should be included in revised diagnostic criteria for chronic migraine.

AB - Introduction: ICHD-3 criteria for chronic migraine (CM) include a mixture of migraine and tension-type-like headaches and do not account for patients who have a high frequency of migraine but no other headaches. Materials and methods: Patients from the Danish Headache Center and their relatives with ICHD-3 defined CM were compared with patients with high frequency episodic migraine (HFEM). Danish registries were used to compare the socioeconomic impact in these two groups. A Russian student population was used to determine the generalizability of the number of patients fulfilling CM and the proposed diagnostic criteria for CM. Results: There was no difference in the demographic profile between the two groups in the Danish cohort. The number of lifelong or annual attacks (p > 0.3), comorbid diseases, or self-reported effect of triptans (p = 1) did not differ. HFEM patients purchased more triptans than CM patients (p = 0.01). CM patients received more early pension (p = 0.00135) but did not differ from HFEM patients with regard to sickness benefit (p = 0.207), cash assistance (p = 0.139), or rehabilitation benefit (p = 1). Discussion: Patients with HFEM are comparable to CM patients with regard to chronicity and disability. We therefore suggest classifying CM as ≥ 8 migraine days per month (proposed CM), disregarding the need for ≥ 15 headache days per month. The proposed diagnostic criteria for CM approximately doubled the number of patients with CM in both the Danish and the Russian materials. Extending the definition of CM to include patients with HFEM will ensure that patients with significant disease burden and unmet treatment needs are identified and provided appropriate access to the range of treatment options and resources available to those with CM. Conclusion: Patients with migraine on eight or more days but not 15 days with headache a month are as disabled as patients with ICHD-3 defined CM. They should be included in revised diagnostic criteria for chronic migraine.

KW - chronic migraine

KW - classification

KW - diagnostic criteria

KW - headache

KW - high frequency episodic migraine

KW - Migraine

UR - http://www.scopus.com/inward/record.url?scp=85073944117&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85073944117&partnerID=8YFLogxK

U2 - 10.1177/0333102419877171

DO - 10.1177/0333102419877171

M3 - Article

C2 - 31544467

AN - SCOPUS:85073944117

JO - Cephalalgia

JF - Cephalalgia

SN - 0333-1024

ER -